Knocking down ALKBH5 inhibited FOXM1 expression in GSCs, and restoring FOXM1 could counteract the consequences of inhibiting ALKBH5 on cell proliferation and tumor formation [21]. The gene discussed is ALKBH5; the disease is neoplasm.